Hostname: page-component-5b777bbd6c-2c8nx Total loading time: 0 Render date: 2025-06-18T22:33:36.079Z Has data issue: false hasContentIssue false
  • English
  • Français

Reverse Potts shunt as rescue from venoarterial extracorporeal membrane oxygenation in pulmonary veno-occlusive disease

Published online by Cambridge University Press:  22 May 2025

Emily Davies Open the ORCID record for Emily Davies [Opens in a new window] ,
Can Yerebakan  and
John T. Berger Open the ORCID record for John T. Berger [Opens in a new window]
Emily Davies
Affiliation:
Division of Pediatric Critical Care Medicine, UMC Children’s Hospital, University Medical Center of Southern Nevada, Las Vegas, NV, USA
Can Yerebakan
Affiliation:
Department of Cardiothoracic Surgery, Nationwide Children’s Hospital, Columbus, OH, USA
John T. Berger*
Affiliation:
Division of Cardiac Critical Care Medicine, Children’s National Hospital, Washington, DC, USA Division of Cardiology, Children’s National Hospital, Washington, DC, USA
*
Corresponding author: John T. Berger; Email: jberger@childrensnational.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Pulmonary veno-occlusive disease has no definitive cure apart from lung transplant. The reverse Potts shunt can be a palliative bridge to transplant. A post-arrest 14-year-old with severe pulmonary veno-occlusive disease on extracorporeal membrane oxygenation support was decannulated after reverse Potts shunt and survived to lung transplant. Reverse Potts shunt should be considered as a rescue in select patients with end-stage pulmonary veno-occlusive disease.

Keywords

Vascular diseaseaortopulmonary shuntpulmonary hypertensionlung physiologyextracorporeal membrane oxygenation
Type
Brief Report
Information
Cardiology in the Young , First View , pp. 1 - 2
Check for updates
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Lantuéjoul, S, Sheppard, MN, Corrin, B, Burke, MM, Nicholson, AG. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006; 30: 850–857.CrossRefGoogle ScholarPubMed
Montani, D, Achouh, L, Dorfmüller, P, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 2008; 87: 220–233.CrossRefGoogle ScholarPubMed
Woerner, C, Cutz, E, Yoo, SJ, Grasemann, H, Humpl, T. Pulmonary venoocclusive disease in childhood. Chest 2014; 146: 167–174.CrossRefGoogle ScholarPubMed
Mandel, J, Mark, EJ, Hales, CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 2000; 162: 1964–1973.CrossRefGoogle ScholarPubMed
Grady, RM, Canter, MW, Wan, F, et al. Pulmonary to-systemic arterial shunt to treat children with severe pulmonary hypertension. J Am Coll Cardiol 2021; 78: 468–477.CrossRefGoogle Scholar
Hayes, D Jr, Jennerich, AL, Coleman, RD, et al. Interventional strategies for children with progressive pulmonary hypertension despite optimal therapy: An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med 2025; 211: 157–173.CrossRefGoogle ScholarPubMed
Rosenzweig, EB, Ankola, A, Krishnan, U, et al. A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults. J Thorac Cardiovasc Surg 2021; 161: 1438–1446.CrossRefGoogle ScholarPubMed